Increase in prevalence of preterm births, owing to factors such as changes in lifestyle, maternal age, and socio-economic factors, is a key contributor to the preterm birth and PROM testing market size. Preterm birth and PROM testing allows healthcare providers to assess the risk of preterm birth and recommend management strategies for better preterm birth output.
Constant innovation in diagnostic technology is also driving the preterm birth and PROM testing industry trajectory. Advancements in preterm natal care technology evolve around enhanced accuracy, non-invasiveness, safety, and speed.
Prominent players in the preterm birth and PROM testing market landscape are investing in point-of-care diagnostic tools and better gene sequencing technology to cater to growing demand from emerging economies with rising populations.
Preterm birth and Premature Rupture of Membranes (PROM) testing is a diagnostic procedure utilized to assess the risk of preterm delivery caused due to genetic abnormalities or premature rupture of the amniotic sac during pregnancy. These tests allow healthcare workers to timely intervene and prevent health risks and fatal emergencies for both the mother and the newborn.
Advantages of preterm birth and PROM testing applied in hospitals, prenatal care centers, and gynecology clinics include early detection of risks, conduction of individualized management and relief methods, and overall minimizing infant mortality and morbidity rates.
Recent preterm birth and PROM testing market trends indicate a focus on the integration of artificial intelligence algorithms for risk prediction and the usage of novel biotechnological innovation for precise and safe early detection.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Evolving lifestyles, maternal age, and rise in occurrences of chronic health issues among pregnant women are some of the major factors contributing to the prevalence of preterm births globally. Moreover, socioeconomic factors and widening income inequality also affect access to prenatal care.
Increase in prevalence of preterm births is propelling the preterm birth and PROM testing market demand. According to the World Health Organization, across countries, the rate of preterm birth ranges from 4–16% of babies born every year. Approximately, nearly 13.4 million babies are born preterm annually. The report also states that three-quarters of these deaths could be prevented with timely interventions.
Preterm and PROM testing plays a vital role in examining and accurately diagnosing pregnant women at risk of premature birth or rupture of critical membranes. These tests assist medical professionals in intervening and designing natal care strategies by offering recommendations or services including medication, lifestyle modification, incubators, and bed rest.
Constant innovations focused on diagnosing genetic disorders for unborn babies and risk for pregnant women gravitate toward improved accuracy, non-invasiveness, safety, and speed. Integration of molecular tools, such as next-generation sequencing (NGS) and imagining techniques including 3D ultrasound, allow for analysis of gene biomarkers and allow professionals to detect potential compilations. Such advancements are contributing to the preterm birth and PROM testing market revenue.
Development of point-of-care testing devices for efficient and accessible screening, coupled with the incorporation of machine learning algorithms for data analytics enhances the ability of natal care workers and medical professionals to design strategies to mitigate risk timely and accurately.
Surge in expenditure on medical technology is boosting the preterm birth and PROM testing market development. As per the Advanced Medical Technology Association, expenditure on medical technology for diagnostic purposes accounts for nearly 5.2% of the total U.S. health expenditure accounting for about US$ 199.1 Bn. Annual costs for diagnostic tests are up to US$ 25 Bn in the world’s most dominant economy.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America had the largest preterm birth and PROM testing market share in 2023. Presence of developed healthcare facilities, rise in number of preterm babies, and surge in demand for natal care are augmenting the market dynamics of the region.
According to the National Center for Health Statistics, in 2022, 380,548 preterm births occurred in the U.S., representing 10.4% of live births. Out of this 5,372 babies were born late preterm and 1,096 babies were born very preterm.
As per the latest preterm birth and PROM testing market regional insights, the industry in Asia Pacific is set to grow at a steady pace from 2024 to 2034. Improved access to healthcare facilities and growth in population in China and India are driving the preterm birth and PROM (Premature Rupture of Membranes) testing market statistics in the region.
Prominent manufacturers operating in the global preterm birth and PROM testing market are investing significantly in developing robust products that help enhance the safety of women and children globally.
Mergers & acquisitions, close research collaborations, and geographical diversity are critical tactics implemented by entities in the preterm birth and PROM testing industry to increase their product portfolio and meet demand from developing countries.
QIAGEN, Hologic, Inc., Medix Biochemica, Biosynex SA, Abbott, Laborie, Sera Prognostics, The Cooper Companies, Inc., NX Prenatal, Inc., and IQ Products are key manufacturers of preterm birth and PROM testing devices.
These companies have been profiled in the preterm birth and PROM testing market report based on parameters such as company overview, financial overview, business strategies, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2023 (Base Year) | US$ 227.8 Mn |
| Market Forecast Value in 2034 | US$ 562.1 Mn |
| Growth Rate (CAGR) | 8.6% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | The qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 227.8 Mn in 2023
It is projected to grow at a CAGR of 8.6% from 2024 to 2034
Increase in prevalence of preterm births and advancements in diagnostic technology
North America dominated the global landscape in 2023
QIAGEN, Hologic, Inc., Medix Biochemica, Biosynex SA, Abbott, Laborie, Sera Prognostics, The Cooper Companies, Inc., NX Prenatal, Inc., and IQ Products
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Preterm Birth and PROM Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Preterm Birth and PROM Testing Market Analysis and Forecast, 2020 - 2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Preterm Birth and PROM Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2020 - 2034
6.3.1. Preterm Birth Tests
6.3.1.1. Pelvic Exam
6.3.1.2. Ultrasound
6.3.1.3. Uterine Monitoring
6.3.1.4. Biomarker
6.3.2. PROM Tests
6.3.2.1. Nitrazine Test
6.3.2.2. Ferning Test
6.3.2.3. Pooling
6.3.2.4. Ultrasound
6.3.2.5. Fetal Fibronectin Test
6.3.2.6. Biomarker Test
6.3.2.7. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global Preterm Birth and PROM Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2020 - 2034
7.3.1. Hospitals
7.3.2. Diagnostics Laboratories
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Preterm Birth and PROM Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020 - 2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Preterm Birth and PROM Testing Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Test Type, 2020 - 2034
9.3.1. Preterm Birth Tests
9.3.1.1. Pelvic Exam
9.3.1.2. Ultrasound
9.3.1.3. Uterine Monitoring
9.3.1.4. Biomarker
9.3.2. PROM Tests
9.3.2.1. Nitrazine Test
9.3.2.2. Ferning Test
9.3.2.3. Pooling
9.3.2.4. Ultrasound
9.3.2.5. Fetal Fibronectin Test
9.3.2.6. Biomarker Test
9.3.2.7. Others
9.4. Market Value Forecast, by End-user, 2020 - 2034
9.4.1. Hospitals
9.4.2. Diagnostics Laboratories
9.4.3. Others
9.5. Market Value Forecast, by Country, 2020 - 2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Test Type
9.6.2. By End-user
9.6.3. By Country
10. Europe Preterm Birth and PROM Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Test Type, 2020 - 2034
10.3.1. Preterm Birth Tests
10.3.1.1. Pelvic Exam
10.3.1.2. Ultrasound
10.3.1.3. Uterine Monitoring
10.3.1.4. Biomarker
10.3.2. PROM Tests
10.3.2.1. Nitrazine Test
10.3.2.2. Ferning Test
10.3.2.3. Pooling
10.3.2.4. Ultrasound
10.3.2.5. Fetal Fibronectin Test
10.3.2.6. Biomarker Test
10.3.2.7. Others
10.4. Market Value Forecast, by End-user, 2020 - 2034
10.4.1. Hospitals
10.4.2. Diagnostics Laboratories
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Preterm Birth and PROM Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Test Type, 2020 - 2034
11.3.1. Preterm Birth Tests
11.3.1.1. Pelvic Exam
11.3.1.2. Ultrasound
11.3.1.3. Uterine Monitoring
11.3.1.4. Biomarker
11.3.2. PROM Tests
11.3.2.1. Nitrazine Test
11.3.2.2. Ferning Test
11.3.2.3. Pooling
11.3.2.4. Ultrasound
11.3.2.5. Fetal Fibronectin Test
11.3.2.6. Biomarker Test
11.3.2.7. Others
11.4. Market Value Forecast, by End-user, 2020 - 2034
11.4.1. Hospitals
11.4.2. Diagnostics Laboratories
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Preterm Birth and PROM Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Test Type, 2020 - 2034
12.3.1. Preterm Birth Tests
12.3.1.1. Pelvic Exam
12.3.1.2. Ultrasound
12.3.1.3. Uterine Monitoring
12.3.1.4. Biomarker
12.3.2. PROM Tests
12.3.2.1. Nitrazine Test
12.3.2.2. Ferning Test
12.3.2.3. Pooling
12.3.2.4. Ultrasound
12.3.2.5. Fetal Fibronectin Test
12.3.2.6. Biomarker Test
12.3.2.7. Others
12.4. Market Value Forecast, by End-user, 2020 - 2034
12.4.1. Hospitals
12.4.2. Diagnostics Laboratories
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Preterm Birth and PROM Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Test Type, 2020 - 2034
13.3.1. Preterm Birth Tests
13.3.1.1. Pelvic Exam
13.3.1.2. Ultrasound
13.3.1.3. Uterine Monitoring
13.3.1.4. Biomarker
13.3.2. PROM Tests
13.3.2.1. Nitrazine Test
13.3.2.2. Ferning Test
13.3.2.3. Pooling
13.3.2.4. Ultrasound
13.3.2.5. Fetal Fibronectin Test
13.3.2.6. Biomarker Test
13.3.2.7. Others
13.4. Market Value Forecast, by End-user, 2020 - 2034
13.4.1. Hospitals
13.4.2. Diagnostics Laboratories
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020 - 2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. QIAGEN
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Hologic, Inc.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Medix Biochemica
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Biosynex SA
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Abbott
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Laborie
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Sera Prognostics
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. The Cooper Companies, Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. NX Prenatal, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. IQ Products
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Test Type, 2020 - 2034
Table 02: Global Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by End-user, 2020 - 2034
Table 03: Global Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Region, 2020 - 2034
Table 04: North America Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Country, 2020 - 2034
Table 05: North America Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Test Type, 2020 - 2034
Table 06: North America Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by End-user, 2020 - 2034
Table 07: Europe Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020 - 2034
Table 08: Europe Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Test Type, 2020 - 2034
Table 09: Europe Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by End-user, 2020 - 2034
Table 10: Asia Pacific Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020 - 2034
Table 11: Asia Pacific Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Test Type, 2020 - 2034
Table 12: Asia Pacific Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by End-user, 2020 - 2034
Table 13: Latin America Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020 - 2034
Table 14: Latin America Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Test Type, 2020 - 2034
Table 15: Latin America Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by End-user, 2020 - 2034
Table 16: Middle East & Africa Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020 - 2034
Table 17: Middle East & Africa Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by Test Type, 2020 - 2034
Table 18: Middle East & Africa Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast, by End-user, 2020 - 2034
List of Figures
Figure 01: Global Preterm Birth and PROM Testing Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Preterm Birth and PROM Testing Market Revenue (US$ Mn), by Test Type, 2023
Figure 03: Global Preterm Birth and PROM Testing Market Value Share, by Test Type, 2023
Figure 04: Global Preterm Birth and PROM Testing Market Revenue (US$ Mn), by End-user, 2023
Figure 05: Global Preterm Birth and PROM Testing Market Value Share, by End-user, 2023
Figure 06: Global Preterm Birth and PROM Testing Market Value Share, by Region, 2023
Figure 07: Global Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast, 2020 - 2034
Figure 08: Global Preterm Birth and PROM Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 09: Global Preterm Birth and PROM Testing Market Attractiveness Analysis, by Test Type, 2024 - 2034
Figure 10: Global Preterm Birth and PROM Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 11: Global Preterm Birth and PROM Testing Market Attractiveness Analysis, by End-user, 2024 - 2034
Figure 12: Global Preterm Birth and PROM Testing Market Value Share Analysis, by Region, 2023 and 2034
Figure 13: Global Preterm Birth and PROM Testing Market Attractiveness Analysis, by Region, 2023-2034
Figure 14: North America Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020 - 2034
Figure 15: North America Preterm Birth and PROM Testing Market Attractiveness Analysis, by Country, 2023–2034
Figure 16: North America Preterm Birth and PROM Testing Market Value Share Analysis, by Country, 2023 and 2034
Figure 17: North America Preterm Birth and PROM Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 18: North America Preterm Birth and PROM Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 19: North America Preterm Birth and PROM Testing Market Attractiveness Analysis, by Test Type, 2024 - 2034
Figure 20: North America Preterm Birth and PROM Testing Market Attractiveness Analysis, by End-user, 2024 - 2034
Figure 21: Europe Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020 - 2034
Figure 22: Europe Preterm Birth and PROM Testing Market Attractiveness Analysis, by Country/Sub-region, 2024 - 2034
Figure 23: Europe Preterm Birth and PROM Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 24: Europe Preterm Birth and PROM Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 25: Europe Preterm Birth and PROM Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 26: Europe Preterm Birth and PROM Testing Market Attractiveness Analysis, by Test Type, 2024 - 2034
Figure 27: Europe Preterm Birth and PROM Testing Market Attractiveness Analysis, by End-user, 2024 - 2034
Figure 28: Asia Pacific Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020 - 2034
Figure 29: Asia Pacific Preterm Birth and PROM Testing Market Attractiveness Analysis, by Country/Sub-region, 2024 - 2034
Figure 30: Asia Pacific Preterm Birth and PROM Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 31: Asia Pacific Preterm Birth and PROM Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 32: Asia Pacific Preterm Birth and PROM Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Asia Pacific Preterm Birth and PROM Testing Market Attractiveness Analysis, by Test Type, 2024 - 2034
Figure 34: Asia Pacific Preterm Birth and PROM Testing Market Attractiveness Analysis, by End-user, 2024 - 2034
Figure 35: Latin America Preterm Birth and PROM Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020 - 2034
Figure 36: Latin America Preterm Birth and PROM Testing Market Attractiveness Analysis, by Country/Sub-region, 2024 - 2034
Figure 37: Latin America Preterm Birth and PROM Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Latin America Preterm Birth and PROM Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 39: Latin America Preterm Birth and PROM Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Latin America Preterm Birth and PROM Testing Market Attractiveness Analysis, by Test Type, 2024 - 2034
Figure 41: Latin America Preterm Birth and PROM Testing Market Attractiveness Analysis, by End-user, 2024 - 2034
Figure 42: Middle East & Africa Preterm Birth and PROM Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020 - 2034
Figure 43: Middle East & Africa Preterm Birth and PROM Testing Market Attractiveness Analysis, by Country/Sub-region, 2024 - 2034
Figure 44: Middle East & Africa Preterm Birth and PROM Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Middle East & Africa Preterm Birth and PROM Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 46: Middle East & Africa Preterm Birth and PROM Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 47: Middle East & Africa Preterm Birth and PROM Testing Market Attractiveness Analysis, by Test Type, 2024 - 2034
Figure 48: Middle East & Africa Preterm Birth and PROM Testing Market Attractiveness Analysis, by End-user, 2024 - 2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Preterm Birth and PROM Testing Market
*86 figures and 60 tables includes